Regression of left ventricular hypertrophy after bilateral nephrectomy

Nephrology Dialysis Transplantation

Volumn 21, Issue 4, 2006, Pages 1089-1091

  Getts, Roger T ^a   Hazlett, Shawn M ^a   Sharma, Sandeep B ^a   McGill, Rita L ^a   Biederman, Robert W W ^a   Marcus, Richard J ^a   Sandroni, Stephen E ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Haemodialysis; Hypertension; Left ventricular hypertrophy; Left ventricular mass index; Magnetic resonance imaging; Nephrectomy

Indexed keywords

CLONIDINE; DILTIAZEM; LISINOPRIL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CASE REPORT; CORONARY ARTERY DISEASE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; KIDNEY CANCER; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; VASCULAR ACCESS;

HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEPHRECTOMY;

EID: 33645294358     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi321     Document Type: Article

References (11)

1. Paoletti E, Specchia C, Di Maio et al. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: A 10 year survey. Nephrol Dial Transplant 2004; 19: 1829-1834
2. Zoccali C, Benedetto FA, Mallamaci F et al. Left ventricular mass monitoring in the follow-up of dialysis patients: Prognostic value of left ventricular hypertrophy progression. Kidney Int 2004; 65: 1492-1498
3. Kanno Y, Kaneko K, Kaneko M et al. Angiotensin receptor antagonist reduces left ventricular hypertrophy associated with diabetic nephropathy in dialysis patients. J Cardiovasc Pharmacol 2004; 43: 380-386
4. Suzuki H, Kanno Y, Kaneko M et al. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy. Ther Apher Dial 2004; 8: 320-327
5. Chuang ML, Beaudin RA, Riley MF et al. Three-dimensional echocardiographic measurement of left ventricular mass: Comparison with magnetic resonance imaging and two-dimensional echocardiographic determinations in man. Int J Cardiac Imag 2000; 16: 347-357
6. Stewart GA, Foster J, Cowan M et al. Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging. Kidney Int 1999; 56: 2248-2253
7. Lee C, Neff MS, Slifkin RF, Leiter E. Bilateral nephrectomy for hypertension in patients with chronic renal failure on a dialysis program. J Urol 1978; 119: 20-22
8. Pitt B, Reichek N, Willenbrock R et al. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: The 4E-left ventricular hypertrophy study. Circulation 2003; 108: 1831-1838
9. Hausberg M, Kosch M, Harmelink P et al. Sympathetic nerve activity in end-stage renal disease. Circulation 2002; 106: 1974-1979
10. Curtis JJ, Luke RG, Dustan HP et al. Remission of essential hypertension after renal transplantation. N Engl J Med 1983; 309: 1009-1015
11. Devereaux RB, Dahlöf B, Gerdts E et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: The losartan intervention for endpoint reduction in hypertension (LIFE) trial. Circulation 2004; 110: 1456-1462